Lanean...
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
In recent years, great progress has been made in the field of new therapeutic options for hepatitis C virus (HCV) infection. The new direct-acting antiviral agents (DAAs) represent a great hope for millions of chronically infected individuals because their use may lead to excellent cure rates with f...
Gorde:
| Argitaratua izan da: | Pharmgenomics Pers Med |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378445/ https://ncbi.nlm.nih.gov/pubmed/28405170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S125452 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|